Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

vertex pharmaceuticals (ch) gmbh - elexacaftorum, tezacaftorum, ivacaftorum - 75 mg, filmtabletten - filmtablette morgendosis (elexacaftorum 50 mg / tezacaftorum 25 mg / ivacaftorum 37.5 mg): elexacaftorum 50 mg, tezacaftorum 25 mg, ivacaftorum 37.5 mg, hypromellosum, hypromellosi acetas succinas, natrii laurilsulfas, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, e 171, talcum, e 172 (flavum), e 172 (rubrum) pro compresso obducto corresp. natrium 1.34 mg. filmtablette abenddosis (ivacaftorum 75 mg): ivacaftorum 75 mg, hypromellosi acetas succinas, natrii laurilsulfas, cellulosum microcristallinum, lactosum monohydricum 83.6 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 132, cera carnauba, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum pro compresso obducto corresp. natrium 0.9 mg. - la fibrosi cistica - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - sitagliptinum - compresse rivestite con film - sitagliptinum 25 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, Überzug: poly(vinylis acetas), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 0.28 mg. - farmaco antidiabetico orale - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - sitagliptinum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, Überzug: poly(vinylis acetas), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 0.56 mg. - farmaco antidiabetico orale - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - sitagliptinum - compresse rivestite con film - sitagliptinum 100 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, Überzug: poly(vinylis acetas), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.12 mg. - farmaco antidiabetico orale - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - sitagliptinum - compresse rivestite con film - sitagliptinum 25 mg ut sitagliptini hydrochloridum monohydricum, calcii hydrogenophosphas, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, natrii stearylis fumaras, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 6000, e 171, e 172 (flavum), e 172 (rubrum), talcum, pro compresso obducto corresp. natrium max. 0.441 mg. - il diabete mellito di tipo 2 - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - sitagliptinum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, calcii hydrogenophosphas, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, natrii stearylis fumaras, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 6000, e 171, e 172 (flavum), e 172 (rubrum), talcum, pro compresso obducto corresp. natrium max. 0.891 mg. - il diabete mellito di tipo 2 - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - sitagliptinum - compresse rivestite con film - sitagliptinum 100 mg ut sitagliptini hydrochloridum monohydricum, calcii hydrogenophosphas, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, natrii stearylis fumaras, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 6000, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), talcum, pro compresso obducto corresp. natrium max. 1.792 mg. - il diabete mellito di tipo 2 - synthetika

Európska únia - taliančina - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - sitagliptinum - compresse rivestite con film - sitagliptinum 25 mg ut sitagliptini hydrochloridum monohydricum, calcii hydrogenophosphas, cellulosum microcristallinum, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, Überzug: lactosum monohydricum 1.20 mg, hypromellosum, e 171, triacetinum, e 172 (rubrum), pro compresso obducto corresp. natrium 0.61 mg. - diabetes typ 2 - synthetika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - sitagliptinum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, calcii hydrogenophosphas, cellulosum microcristallinum, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.23 mg. - diabetes typ 2 - synthetika